A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616] ; volume:5 ; number:1 ; day:25 ; month:3 ; year:2004 ; pages:1-9 ; date:12.2004
BMC nephrology ; 5, Heft 1 (25.3.2004), 1-9, 12.2004
- Beteiligte Personen und Organisationen
-
Hogg, Ronald J.
Wyatt, Robert J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2369-5-3
- URN
-
urn:nbn:de:1111-2016081218634
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hogg, Ronald J.
- Wyatt, Robert J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
IgA nephropathy today : 10 tables
Current treatment of IgA nephropathy
Current treatment of IgA nephropathy
Complement activation in IgA nephropathy
IgA Nephropathy: A Chinese Perspective
Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
IgA nephropathy today : 10 tables
Current treatment of IgA nephropathy
Current treatment of IgA nephropathy
Complement activation in IgA nephropathy
IgA Nephropathy: A Chinese Perspective
Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
IgA nephropathy today : 10 tables
Current treatment of IgA nephropathy
Current treatment of IgA nephropathy
Complement activation in IgA nephropathy
IgA Nephropathy: A Chinese Perspective
Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy